Nyla Pharmaceuticals Private Limited
About Nyla Pharmaceuticals Private Limited
Data last updated:
Nyla Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2014PTC255717. Its GSTIN is 27AAECN7357C1ZF (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sagarmal Sharad Amrutkar and Swapnil Ashok Gore.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at N – 7 B – 1 – 66 Cidco, Aurangabad, Maharashtra, India – 431003.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.78 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹22,786 (net margin 0.7%) and EBITDA of ₹22,786 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressN – 7 B – 1 – 66 Cidco, Aurangabad, Maharashtra, India – 431003
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nyla Pharmaceuticals Private Limited
The main business activity of Nyla Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nyla Pharmaceuticals Private Limited FY 2024 filings available
Nyla Pharmaceuticals Private Limited reported revenue of ₹33.78 Lakh (down 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Nyla Pharmaceuticals Private Limited
Revenue fell 24% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nyla Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹22,786 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹22,786 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nyla Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nyla Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nyla Pharmaceuticals Private Limited
Nyla Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sagarmal Sharad Amrutkar | Director | 27 Jun 2014 | 12 Years 3 Months | Current |
| Swapnil Ashok Gore | Director | 27 Jun 2014 | 12 Years 3 Months | Current |
Peer Comparison of Nyla Pharmaceuticals Private Limited
Nyla Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Symbicure Pharmaceuticals Private Limited | ₹33.99 Lakh (FY 2024) | •••• | •••• | 41.0% | •••• | Vadodara, Gujarat, India |
| Aarati Pharmaceuticals Private Limited | ₹33.93 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Yuva Cosmoderm Private Limited | ₹33.93 Lakh (FY 2025) | •••• | •••• | -91.0% | •••• | Pune, Maharashtra, India |
| Adhisvar Pharmaceuticals Private Limited | ₹33.85 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Vadodara, Gujarat, India |
| Saskia Healthcare Private Limited | ₹33.79 Lakh (FY 2024) | •••• | •••• | 63.0% | •••• | Ahmedabad, Gujarat, India |
| Nyla Pharmaceuticals Private Limited this company | ₹33.78 Lakh (FY 2024) | •••• | •••• | -24.0% | •••• | Aurangabad, Maharashtra, India |
| Symbirx Lifesciences Private Limited | ₹33.78 Lakh (FY 2025) | •••• | •••• | 59.0% | •••• | Pune, Maharashtra, India |
| LN Pharmaceuticals Private Limited | ₹33.71 Lakh (FY 2025) | •••• | •••• | 447.0% | •••• | Hyderabad, Telangana, India |
| Apa Pharma Private Limited | ₹33.7 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Delhi, India |
| Roxas Pharmaceuticals Private Limited | ₹33.66 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Delhi, India |
| Solera Life Sciences Private Limited | ₹33.63 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Nyla Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nyla Pharmaceuticals Private Limited
Auditor information for Nyla Pharmaceuticals Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Ownership and Shareholding of Nyla Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nyla Pharmaceuticals Private Limited
Nyla Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nyla Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Nyla Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nyla Pharmaceuticals Private Limited
Nyla Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Ashish Kailassinh Chandel ceased to be Director on 05 Oct 2018.
Credit Ratings, Litigation & Regulatory Alerts for Nyla Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nyla Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nyla Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nyla Pharmaceuticals Private Limited
Nyla Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECN7357C1ZF | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nyla Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nyla Pharmaceuticals Private Limited
Nyla Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 June 2014 (12+ years old) and is registered under CIN U51909MH2014PTC255717.
Nyla Pharmaceuticals reported revenue of ₹33.78 Lakh for FY 2024 (down 24% YoY).
Nyla Pharmaceuticals has 2 current directors:
- Sagarmal Sharad Amrutkar - Director
- Swapnil Ashok Gore - Director
Nyla Pharmaceuticals reported a net profit of ₹22,786 (net margin 0.7%) and EBITDA of ₹22,786 (EBITDA margin 0.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nyla Pharmaceuticals is -15% over three years and 3% over five years. In the latest year (FY 2024) revenue fell 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nyla Pharmaceuticals is 27AAECN7357C1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nyla Pharmaceuticals is U51909MH2014PTC255717. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nyla Pharmaceuticals was incorporated on 27 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Nyla Pharmaceuticals by revenue are Symbicure Pharmaceuticals Private Limited, Aarati Pharmaceuticals Private Limited, Yuva Cosmoderm Private Limited, Adhisvar Pharmaceuticals Private Limited, Saskia Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Ashish Kailassinh Chandel ceased to be Director on 05 Oct 2018. Sagarmal Sharad Amrutkar was appointed as Director on 27 Jun 2014. Swapnil Ashok Gore was appointed as Director on 27 Jun 2014.
The registered office of Nyla Pharmaceuticals is at N – 7 B – 1 – 66 Cidco, Aurangabad, Maharashtra, India – 431003.